Joined March 2012
13 Photos and videos
A/Prof Ashwin Subramaniam retweeted
Latest offering SRMA of in-hospital cardiac arrests in ICU These are very different to IHCAs on the ward pubmed.ncbi.nlm.nih.gov/2432… pubmed.ncbi.nlm.nih.gov/4176… pubmed.ncbi.nlm.nih.gov/3146… @catchdrash @JuditOrosz4 @PoundGemma
4
13
929
A/Prof Ashwin Subramaniam retweeted
19 Sep 2025
Preliminary Program Now Available! We’re excited to announce that the preliminary program for the upcoming Safety and Quality Conference is now live. 👉 anzics.org/wp-content/upload… This year’s theme, “Care 365: Our Patients. Our Staff. Our Environment”, reflects our unwavering commitment to delivering safe, high-quality care in intensive care. The program features a dynamic lineup of keynote speakers, interactive sessions, and thought-provoking panels designed to inspire and empower healthcare professionals across all disciplines. Explore topics including: 🔹 Patient-centred care innovations 🔹 Staff well-being 🔹 Sustainable healthcare practices 🔹 System-wide quality improvement strategies Whether you’re an Intensivist, nurse, allied health professional, or research coordinator — this conference has something for you. 👉 Don’t miss out! Register now and be part of the conversation shaping the future of safety and quality in healthcare. anzics.org/anzics-safety-qua… #SafetyAndQuality #IntensiveCare #HealthcareInnovation #ANZICS
2
2
257
A/Prof Ashwin Subramaniam retweeted
16 Sep 2025
🚨 Less Than 1 Month to Go! 🚨 The countdown is on for the 2025 Safety & Quality Conference – Care 365. While the early bird window has now closed, there’s still time to secure your place! Join leading clinicians, innovators, and changemakers in Sydney from October 9–11 as we explore the future of safety, quality, and sustainability in intensive care. 👉 Register now: anzics.org/anzics-safety-qua… #ANZICS #Care365 #SafetyAndQuality #ICU
2
1
310
A/Prof Ashwin Subramaniam retweeted
Both delirium 😵‍💫 & frailty 🚫💪 are important predictors of mortality in ICU patients… but do they interact to associate w harm? 👀 at @catchdrash et al’s new study, just out in #journal_CHESTCritCare, to find out: chestcc.org/article/S2949-78…
5
9
679
RT @yourICM: Outcome of #IHCA in periop vs ward settings 🔍@anzics dataset 🇦🇺 >5.6K IHCAs 🔪38% periop IHCA: younger, less frail/comorbid, m…
8
A/Prof Ashwin Subramaniam retweeted
Outcome of #IHCA in periop vs ward settings 🔍@anzics dataset 🇦🇺 >5.6K IHCAs 🔪38% periop IHCA: younger, less frail/comorbid, most frequently admitted after CV, GI, #trauma surgery 🪦periop: better survival 59.9% vs 33%, all subgroups 🔓rdcu.be/dT5fQ ⬇️visual abstract
5
11
4,130
A/Prof Ashwin Subramaniam retweeted
An ICM highlight paper by @Intensive_Ryo & @anzics at #ESICM @ESICM Great summary by @CombesProf
3
16
1,199
A/Prof Ashwin Subramaniam retweeted
Countdown is on to @CritCareReviews Down Under! 🇦🇺Discover the world's best clinical trials all in one place 🐨 Extensive scientific and social program 🦘No need to travel to Belfast! CCR Down Under 10 & 11 Dec 2024 Melbourne, Australia Register now web.cvent.com/event/36a92986…
3
4
814
A/Prof Ashwin Subramaniam retweeted
I believe that #ECMO is a life-saving temporising intervention. Yet, there are ethical dilemmas when it appears "futile". In @LancetRespirMed, @kshekar01 @KrKrramanathan and I envision a future where ECMO can be reliably used as a long-term device. thelancet.com/journals/lanre…
3
10
947
A/Prof Ashwin Subramaniam retweeted
🧐 What is the burden of AHRF in ICUs? 🫂 ANZICS APD 2005-2024: 1.5m patients with ABGs 🫁 >50% had AHRF within 24h of ICU admission! 🪦 Mortality ⬆️with worsening P/F ratios, esp <200. ⏲️ Mortality ⬇️ with time, but not unique to AHRF alone... 🔓 bit.ly/3Xrdh8E #FOAMed
1
6
10
804
RT @yourICM: Acute hypoxemic respiratory failure in #ICU in 🇦🇺🇳🇿: disease burden may be higher than expected! 🪦mortality ⬆️ with ⬇️ P/F, pa…
24
A/Prof Ashwin Subramaniam retweeted
4y survival of #IHCA in perioperative vs ward settings Are they different?🙋‍♂️ what if intubated? 🫀 What if elderly? 👴 What if after emergency surgery? 🆘 Check this out 🆕 @yourICM
Outcome of #IHCA in perioperative vs ward settings 🔍@anzics dataset 🇦🇺: >5.6K IHCAs 🔪38% periop IHCA: younger, less frail/comorbid, most frequently admitted after CV, GI, #trauma surgery 🪦periop: longer 4y survival 59.9% vs 33% across all subgroups 🖇️ bit.ly/3LUSJim
5
12
2,438
RT @yourICM: Outcome of #IHCA in perioperative vs ward settings 🔍@anzics dataset 🇦🇺: >5.6K IHCAs 🔪38% periop IHCA: younger, less frail/com…
14
A/Prof Ashwin Subramaniam retweeted
Well done @Intensive_Ryo @catchdrash Very important work highlighting the importance of 1. the association of frailty with outcomes of IHCA 2. deploying CPR in appropriate patients 3. the need to have goals of care discussions with inpatients
Frail pt admitted to ICU after in-hospital-cardiac-arrest 🆘 🏥 What is one-year survival? ⏱️ How much is frailty associated with mortality compared to other risk factors? 👴 Check this out! doi.org/10.1016/j.jcrc.2024.… @jones_daza @IntensiveDave @catchdrash @anzics @anzicrc
2
2
295
A/Prof Ashwin Subramaniam retweeted
Frail pt admitted to ICU after in-hospital-cardiac-arrest 🆘 🏥 What is one-year survival? ⏱️ How much is frailty associated with mortality compared to other risk factors? 👴 Check this out! doi.org/10.1016/j.jcrc.2024.… @jones_daza @IntensiveDave @catchdrash @anzics @anzicrc

7
14
2,148
A/Prof Ashwin Subramaniam retweeted
Published in @TheLancet , a recent study undertaken by Peninsula Health specialists Dr Mallikarjuna Ponnapa Reddy, A/Prof Ashwin Subramaniam and their team has suggested some significant COVID-19 related findings. bit.ly/3UTLH0o

1
4
A/Prof Ashwin Subramaniam retweeted
With an excellent, insightful commentary by Marcus Schultz, David van Meenen, and @Acute_Pulmo_Med on the lessons learnt during the pandemic.
2
4
A/Prof Ashwin Subramaniam retweeted
- No compliance based subphenotypes observed in COVID-related ARDS - Making changes to conventional ventilatory strategies/adopting newer strategies based on scarce evidence in emerging infectious respiratory pathologies can be deleterious.@LancetRespirMed
New meta-analysis on #COVID #ARDS #phenotypes out in @LancetRespirMed: 🫁 compliance is NORMALLY distributed 📠 vent. management for #COVID #ARDS should not differ from non-COVID-19 ARDS 👨‍👩‍👧‍👦 more patient-level analyses needed sciencedirect.com/science/ar…
4
10
A/Prof Ashwin Subramaniam retweeted
New meta-analysis on #COVID #ARDS #phenotypes out in @LancetRespirMed: 🫁 compliance is NORMALLY distributed 📠 vent. management for #COVID #ARDS should not differ from non-COVID-19 ARDS 👨‍👩‍👧‍👦 more patient-level analyses needed sciencedirect.com/science/ar…
1
8
18
Well done. Thanks Malli Reddy for leading this project. Thanks to all who were involved. @kshekar01 @ryanryling @KrKrramanathan @PeninsulaHealth
4
6